Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Brancolini

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Advances in Clinical Pathology : the Official Journal of Adriatic Society of Pathology|September 17, 2009
IAPs: the last choice to surviveClaudio Brancolini
Biomolecules|August 28, 2025
Class IIa HDACs Are Important Signal Transducers with Unclear Enzymatic ActivitiesClaudio Brancolini
Current Molecular Pharmacology|December 22, 2009
Inhibitors of the Ubiquitin-Proteasome System and the cell death machinery: How many pathways are activated?Claudio Brancolini
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2011
Measurement of caspase activity: from cell populations to individual cellsGabriela Paroni, Claudio Brancolini
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 13, 2006
Altering protein turnover in tumor cells: new opportunities for anti-cancer therapiesFrancesca Demarchi, Claudio Brancolini
Cancers|March 6, 2021
Epigenetic Mechanisms beyond Tumour-Stroma CrosstalkTeresa Gagliano, Claudio Brancolini
Cancers|August 27, 2020
Proteotoxic Stress and Cell Death in Cancer CellsClaudio Brancolini, Luca Iuliano
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2003
Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotypeClare Henderson, Claudio Brancolini
Cytokine & Growth Factor Reviews|August 22, 2012
IFNs, ISGylation and cancer: Cui prodest?Andrea Sgorbissa, Claudio Brancolini
Epigenomics|January 22, 2016
Regulation of class IIa HDAC activities: it is not only matter of subcellular localizationEros Di Giorgio, Claudio Brancolini
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Advances in Clinical Pathology : the Official Journal of Adriatic Society of Pathology|September 17, 2009
IAPs: the last choice to surviveClaudio Brancolini
Biomolecules|August 28, 2025
Class IIa HDACs Are Important Signal Transducers with Unclear Enzymatic ActivitiesClaudio Brancolini
Current Molecular Pharmacology|December 22, 2009
Inhibitors of the Ubiquitin-Proteasome System and the cell death machinery: How many pathways are activated?Claudio Brancolini
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2011
Measurement of caspase activity: from cell populations to individual cellsGabriela Paroni, Claudio Brancolini
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 13, 2006
Altering protein turnover in tumor cells: new opportunities for anti-cancer therapiesFrancesca Demarchi, Claudio Brancolini
Cancers|March 6, 2021
Epigenetic Mechanisms beyond Tumour-Stroma CrosstalkTeresa Gagliano, Claudio Brancolini
Cancers|August 27, 2020
Proteotoxic Stress and Cell Death in Cancer CellsClaudio Brancolini, Luca Iuliano
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2003
Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotypeClare Henderson, Claudio Brancolini
Cytokine & Growth Factor Reviews|August 22, 2012
IFNs, ISGylation and cancer: Cui prodest?Andrea Sgorbissa, Claudio Brancolini
Epigenomics|January 22, 2016
Regulation of class IIa HDAC activities: it is not only matter of subcellular localizationEros Di Giorgio, Claudio Brancolini
Pageof 8